Highbridge Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-14,224
| Closed | -$2.74M | – | 440 |
|
|
2018
Q3 | $2.74M | Buy |
+14,224
| New | +$2.74M | 0.07% | 232 |
|
|
2018
Q1 | – | Sell |
-15,000
| Closed | -$2.25M | – | 1137 |
|
|
2017
Q4 | $2.25M | Buy |
+15,000
| New | +$2.25M | 0.04% | 306 |
|
|
2017
Q3 | – | Sell |
-1,900
| Closed | -$245K | – | 1138 |
|
|
2017
Q2 | $245K | Sell |
1,900
-26,037
| -93% | -$3.36M | ﹤0.01% | 701 |
|
|
2017
Q1 | $3.06M | Buy |
27,937
+22,937
| +459% | +$2.51M | 0.04% | 328 |
|
|
2016
Q4 | $368K | Hold |
5,000
| – | – | 0.01% | 726 |
|
|
2016
Q3 | $436K | Buy |
+5,000
| New | +$436K | 0.01% | 715 |
|
|
2016
Q2 | – | Sell |
-13,980
| Closed | -$1.11M | – | 1321 |
|
|
2016
Q1 | $1.11M | Buy |
+13,980
| New | +$1.11M | 0.02% | 414 |
|
|
2015
Q4 | – | Sell |
-19,852
| Closed | -$2.07M | – | 1142 |
|
|
2015
Q3 | $2.07M | Buy |
+19,852
| New | +$2.07M | 0.03% | 399 |
|
|
2015
Q2 | – | Sell |
-3,201
| Closed | -$378K | – | 1100 |
|
|
2015
Q1 | $378K | Buy |
+3,201
| New | +$378K | 0.01% | 626 |
|
|
2014
Q3 | – | Sell |
-88,359
| Closed | -$8.37M | – | 1018 |
|
|
2014
Q2 | $8.37M | Buy |
+88,359
| New | +$8.37M | 0.1% | 194 |
|
|
2013
Q4 | – | Sell |
-123,181
| Closed | -$9.34M | – | 971 |
|
|
2013
Q3 | $9.34M | Buy |
123,181
+30,844
| +33% | +$2.34M | 0.1% | 236 |
|
|
2013
Q2 | $7.39M | Buy |
+92,337
| New | +$7.39M | 0.07% | 260 |
|